TSC CONNECTED CARE
LIVE

Serial Number

79392547

Owner

Sensium Healthcare Limited

Attorney

Roger H. Bora

Filing Date

Nov 15, 2023

Add to watchlist:

No watchlists yet
View on USPTO

TSC CONNECTED CARE Trademark

Serial Number: 79392547 • Registration: 7749322

TSC CONNECTED CARE is a trademark filed by Sensium Healthcare Limited on November 15, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Sensium Healthcare Limited

115 Olympic Avenue,

Entity Type: 99

Trademark Details

Filing Date

November 15, 2023

Registration Date

April 8, 2025

Published for Opposition

February 18, 2025

Goods & Services

Analysis of business data derived from sensors, biosensors, chemical and optical sensors; collection and systemisation of information into computer databases; collection and systemisation of information into computer databases in the field of medical, physiological, and biochemical information and data; business consultation services relating to collection, preparation, composition and processing of medical, physiological, and biochemical information and data; information, consultancy and advisory services related to all the aforesaid services

Human healthcare services; medical services related to medication safety, self-efficacy and medication adherence; remote monitoring of medical data for medical treatment; medical information services provided via the internet; healthcare information, consultancy and advisory services; providing medical information in the healthcare sector; providing medical information, namely, providing analysis and information reports based upon results from medical testing and treatment; medical services provided remotely via software applications for mobile telephones, tablet computers and other portable electronic devices; information, consultancy and advisory services related to all the aforesaid services

Medical devices and apparatus, namely, wireless sensors for use in the continuous, remote monitoring of an individual's temperature, blood glucose levels, physical activity, oxygen levels and other vital signs and also including communication platforms sold as a unit; medical diagnostic and sensing devices and apparatus, namely, sensors that can be attached to the body with a sticking plaster to enable non-intrusive, continuous monitoring and analysis of an individual's temperature, blood glucose levels, physical activity, oxygen levels, and other vital signs; medical devices and instruments incorporating wireless communication devices and sensors, biosensors, chemical sensors and optical sensors, namely, elastic bandages for use in the continuous, remote monitoring of an individual's temperature, blood glucose levels, physical activity, oxygen levels, and other vital signs

Diagnostic preparations for medical or veterinary purposes

Design and development of software and hardware for sensing, monitoring, recording and transmission of signals and information; design and development of software and hardware for use with wireless communication devices, biosensors, chemical sensors, electrical and optical sensors; temporary electronic storage of business information related to medical, physiological, and biochemical data; electronic data storage consultation services relating to medical, physiological, and biochemical information and data; scientific research and consultancy services relating to the design and development of sensing, monitoring, recording and processing apparatus, wireless communication devices, biosensors, chemical sensors, electrical and optical sensors; technical support services, namely, troubleshooting in the nature of diagnosing computer hardware and software problems; technical support services, namely, monitoring technological functions of computer network systems in the field of engineering; scientific and technological services, namely, analysis of technical data derived from sensors, biosensors, chemical and optical sensors; providing online non-downloadable software for use in monitoring, analysing and communicating medication safety, self-efficacy and medication adherence; Software as a Service (SaaS) services featuring software for sensing, monitoring, recording and transmission of signals, data and information; Platform as a Service (PaaS) services featuring software for sensing, monitoring, recording and transmission of signals, data and information; information, consultancy and advisory services related to all the aforesaid services

Electric or electronic sensors for sensing, monitoring, recording and transmission of signals and information for monitoring physiological parameters of the body for scientific use; wireless transmitters and receivers; biosensors, namely, sensors for measuring physiological parameters of the body, not for medical use, chemical sensors for scientific use for use in wireless body monitoring, electrical and optical sensors; body wearable and implantable sensors that interface with mobile telephones, pdas and computers for use in continuous vital sign, biochemical and physiological monitoring, all for scientific use, and receiving and processing apparatus therefor, namely base stations and mobile computing and operating platforms consisting of data transceivers, wireless networks, and gateways for collection and management of physiological and medical data; remote monitoring apparatus for monitoring physiological parameters of the body for scientific use; downloadable remote monitoring software for monitoring physiological parameters of the body for scientific use; downloadable health monitoring software for controlling and managing patient medical information; downloadable communications software for connecting computer network users, namely, patients and medical professionals; recorded software for the transmission of medical data and information; apparatus for transmission of sound, images or data in the field of medical data and information; recorded software for recording medical data; downloadable software for use in monitoring, analysing and communicating medication safety, self-efficacy and medication adherence; downloadable software for monitoring medical data and vital statistics; recorded and downloadable, computer software for monitoring physiological parameters of the body; recorded computer software using artificial intelligence for monitoring physiological parameters of the body, for scientific purposes; downloadable computer software for monitoring physiological parameters of the body, for scientific purposes; downloadable software for portable electronic devices for monitoring and measuring physiological parameters of the body, for scientific purposes; downloadable computer software for the transmission of data and information

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Nov 7, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Oct 21, 2025 FICS
FINAL DISPOSITION PROCESSED
Oct 21, 2025 FIMP
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Sep 12, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 27, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Aug 27, 2025 OPNR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jul 8, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 8, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Apr 8, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 18, 2025 NPUB
PUBLISHED FOR OPPOSITION
Feb 18, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 12, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 27, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 13, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 13, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 13, 2025 TROA
REFUSAL PROCESSED BY IB
Aug 4, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 15, 2024 RFCS
REFUSAL PROCESSED BY MPU
Jul 15, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 22, 2024 RFCR
NON-FINAL ACTION WRITTEN
Jun 21, 2024 CNRT
ASSIGNED TO EXAMINER
Jun 20, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Apr 5, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 1, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 28, 2024 REPR